http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0233800-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate | 1987-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82d47e3851d9c6915e766c54b97af0e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3c2c4a5254f0881ebcca1bb74a5902d |
| publicationDate | 1987-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0233800-A1 |
| titleOfInvention | Imidazo[1,2-a]quinoline derivatives, their preparation and therapeutical use thereof |
| abstract | X représente l'hydrogène, un halogène ou un groupe (C 1 - 4 )alkyle, (C 1-4 )alcoxy, (C 1 4 )alkylthio, méthylsulfonyle, amino, (C 1-4 )alkylamino, di-(C 1-4 )alkylamino, nitro ou trifluoroalkyle, Y représente l'hydrogène, un halogène ou un groupe méthyle en position 6, 7 ou 8 et, R1 et R2 pris séparément, représentent chacun l'hydrogène ou un groupe (C 1-6 )alkyle, ou bien R1 et R2 forment ensemble und chaîne tétraméthylène, pentaméthylène, méthyl-3 aza-3 pentaméthylène ou oxa-3 p e ntaméth y lè ne, nainsi que leurs sels d'addition acceptables en pharmacologie.Compounds corresponding to the general formula (I) in which X represents hydrogen, a halogen or a (C 1 - 4 ) alkyl, (C 1-4 ) alkoxy, (C 1 4 ) alkylthio, methylsulfonyl, amino, (C 1-4 ) alkylamino, di- (C 1-4 ) alkylamino, nitro or trifluoroalkyl, Y represents hydrogen, a halogen or a methyl group in position 6, 7 or 8 and, R1 and R2 taken separately, each represent hydrogen or a (C 1-6 ) alkyl group, or else R1 and R2 together form a tetramethylene, pentamethylene, 3-methyl-3-aza-3 pentamethylene or oxa-3 p e ntameth y lene chain , as well as their addition salts acceptable in pharmacology.n n n Application in therapy. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2759700-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9700074-A1 |
| priorityDate | 1986-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.